Table 3. In-hospital and long-term outcomes.
Vascular access | TR (n = 59) | TF (n = 67) | P value |
Mean hospital stay (days) | 5.1 ± 16.5 | 9.2 ± 20.6 | 0.671 |
In-hospital outcomes | |||
Non-cardiac death | 0 (0%) | 1 (1%) | 0.883 |
Acute stent thrombosis | 1 (2%) | 2 (3%) | 0.911 |
Post-procedural myocardial infarction | 1 (2%) | 2 (3%) | 0.911 |
Post-procedural myonecrosis | 10 (17%) | 12 (18%) | 0.926 |
Major access site bleeding | 1 (2%) | 11 (16%) | 0.012 |
Long-term outcomes | |||
Non-cardiac death | 3 (5%) | 3 (4%) | 0.795 |
Non-fatal myocardial infarction | 1 (2%) | 2 (3%) | 0.911 |
Non-fatal stroke | 0 (0%) | 3 (4%) | 0.289 |
Target vessel revascularization | 6 (10%) | 8 (12%) | 0.975 |
Data are expressed as mean ± SD or n (%). TF: transfemoral; TR: transradial.